Chen, Cunte http://orcid.org/0000-0003-3733-9174
Liu, Siyang Maggie http://orcid.org/0000-0002-3837-0758
Chen, Yedan http://orcid.org/0000-0002-7942-5540
Ou, Qiuxiang http://orcid.org/0000-0002-2961-2057
Bao, Hua http://orcid.org/0000-0001-5774-8755
Xu, Ling http://orcid.org/0000-0002-7044-7663
Zhang, Yikai http://orcid.org/0000-0002-6851-6260
Zhang, Jia-Tao http://orcid.org/0000-0003-4302-9332
Zhong, Wenzhao http://orcid.org/0000-0002-4000-6402
Zhou, Qing http://orcid.org/0000-0002-0478-176X
Yang, Xue-Ning http://orcid.org/0000-0002-8346-2117
Shao, Yang http://orcid.org/0000-0003-4585-1792
Wu, Yi-Long http://orcid.org/0000-0002-3611-0258
Liu, Si-Yang http://orcid.org/0000-0002-5105-6421
Li, Yangqiu http://orcid.org/0000-0002-0974-4036
Funding for this research was provided by:
China Postdoctoral Science Foundation (2021M701422)
Guangdong Provincial Key Laboratory of Lung Cancer Translational Medicine (2017B030314120)
National Natural Science Foundation of China (82002413)
Guangdong Provincial Applied Science and Technology Research and Development Program (2016B020237006)
Article History
Received: 20 April 2022
Accepted: 15 November 2022
First Online: 24 November 2022
Declarations
:
: Yi-Long Wu discloses the following personal financial interest: Consulting and advisory services, speaking engagements for Roche, AstraZeneca, Eli Lilly, Boehringer Ingelheim, Sanofi, MSD, and BMS. Yedan Chen, Qiuxiang Ou, Hua Bao and Yang Shao are the employees of Nanjing Geneseeq Techology Inc.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Guangdong Provincial People's Hospital (No. 2011713).
: Written informed consent was received from participants before inclusion in the study. Participants were identified by number, not by name.